Modulation of tumor-associated lymphangiogenesis by combination immunotherapy approaches in triple-negative breast cancer: a systematic review.

Guerrero-Sánchez M, Martens L, García-Caballero M.

Open source

DOI
10.3389/fimmu.2026.1641259
Published
2026-04-21
Container
Front Immunol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1641259,
  title = {Modulation of tumor-associated lymphangiogenesis by combination immunotherapy approaches in triple-negative breast cancer: a systematic review.},
  author = {Guerrero-Sánchez M and  Martens L and  García-Caballero M.},
  year = {2026},
  journal = {Front Immunol},
  doi = {10.3389/fimmu.2026.1641259},
  url = {https://doi.org/10.3389/fimmu.2026.1641259}
}

RIS

TY  - JOUR
TI  - Modulation of tumor-associated lymphangiogenesis by combination immunotherapy approaches in triple-negative breast cancer: a systematic review.
AU  - Guerrero-Sánchez M
AU  -  Martens L
AU  -  García-Caballero M.
PY  - 2026
JO  - Front Immunol
DO  - 10.3389/fimmu.2026.1641259
UR  - https://doi.org/10.3389/fimmu.2026.1641259
ER  - 

APA

M, G., L, M., & M., G. (2026). Modulation of tumor-associated lymphangiogenesis by combination immunotherapy approaches in triple-negative breast cancer: a systematic review.. Front Immunol. https://doi.org/10.3389/fimmu.2026.1641259

Source records